blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3412278

EP3412278 - PHARMACEUTICAL DOSAGE FORMS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.11.2020
Database last updated on 16.11.2024
FormerGrant of patent is intended
Status updated on  11.02.2020
FormerRequest for examination was made
Status updated on  22.11.2019
FormerGrant of patent is intended
Status updated on  24.07.2019
FormerRequest for examination was made
Status updated on  21.06.2019
FormerThe application has been published
Status updated on  09.11.2018
Most recent event   Tooltip20.11.2020Application deemed to be withdrawnpublished on 23.12.2020  [2020/52]
Applicant(s)For all designated states
Recordati AG
Lindenstrasse 8
6340 Baar / CH
[2020/10]
Former [2018/50]For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
Inventor(s)01 / BEATO, Stefania
Novartis Pharma AG
Postfach
4002 Basel / CH
02 / QUINTON, Peggy
Novartis Pharma AG
Postfach
4002 Basel / CH
 [2018/50]
Representative(s)Pistolesi, Roberto, et al
Dragotti & Associati Srl
Via Nino Bixio, 7
20129 Milano / IT
[N/P]
Former [2018/50]Petersen, Holger
Novartis Pharma AG
Postfach
4002 Basel / CH
Application number, filing date18176177.606.07.2015
[2018/50]
Priority number, dateUS201462021271P07.07.2014         Original published format: US 201462021271 P
[2018/50]
Previously filed application, dateWO2015IB5509806.07.2015
[2018/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3412278
Date:12.12.2018
Language:EN
[2018/50]
Search report(s)(Supplementary) European search report - dispatched on:EP04.10.2018
ClassificationIPC:A61K9/20, A61K31/45
[2018/50]
CPC:
A61K9/2036 (EP,EA,IL,KR,US); A61K9/2054 (EP,CN,EA,IL,KR,US); A61K9/0053 (CN,EA,IL);
A61K31/4188 (CN,EA,IL,US); A61K31/4184 (EP,EA,IL,US); A61K31/45 (EA,IL,KR);
A61K9/20 (IL); A61K9/2009 (EA,IL,US); A61K9/2095 (EA,IL,US);
A61K9/2806 (CN,EA,IL); A61K9/2813 (EA,IL,US); A61K9/2826 (EA,IL,US);
A61K9/2866 (EA,IL,US); A61P13/12 (EP,IL); A61P5/46 (EP,IL) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/30]
Former [2018/50]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:DOSIERFORMEN FÜR ARZNEIMITTEL[2018/50]
English:PHARMACEUTICAL DOSAGE FORMS[2018/50]
French:FORMES PHARMACEUTIQUES[2018/50]
Examination procedure07.06.2019Amendment by applicant (claims and/or description)
12.06.2019Examination requested  [2019/30]
12.06.2019Date on which the examining division has become responsible
25.07.2019Communication of intention to grant the patent
21.11.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
12.02.2020Communication of intention to grant the patent
23.06.2020Application deemed to be withdrawn, date of legal effect  [2020/52]
05.08.2020Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2020/52]
Parent application(s)   TooltipEP15738484.3  / EP3166596
Fees paidRenewal fee
16.11.2018Renewal fee patent year 03
16.11.2018Renewal fee patent year 04
15.07.2019Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.07.202006   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]WO2011088188  (NOVARTIS AG [CH], et al) [AD] 1-18* example -; claim - *;
 [A]WO2013153129  (NOVARTIS AG [CH], et al) [A] 1-18 * example -; claim - *;
 [AP]EP2815749  (IP GES FÜR MAN MBH [DE]) [AP] 1-18 * paragraphs [0008] , [0025] - [0028] - [0051] - [0078] - [0096] , [0121] , [0167] , [0296] - [0298] * * example 20 * * claim - *
by applicantWO2007024945
 WO2011088188
 WO2013109514
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.